(Total Views: 539)
Posted On: 04/28/2020 2:34:37 PM
Post# of 145882
I was never quite clear on the HC Wainwright connection. The analyst asks questions on every conference call but many of the times seems to join the call late and asks questions that have already been covered. I did find that they had some involvement in earlier placements though. Perhaps that is why they follow us, a bit of a professional courtesy?
For example...
For example...
Quote:
VANCOUVER, Washington, September 12, 2016 (GLOBE NEWSWIRE) — CytoDyn Inc. (OTC.QB:CYDY), a biotechnology company focused on the development of new antibody therapies for combating human immunodeficiency virus (HIV) infection, today announced that it has entered into definitive agreements with healthcare dedicated institutional investors for an offering of 13,333,334 shares of common stock, at a price per share of $0.75, and warrants to purchase 6,666,667 shares of common stock with gross proceeds of approximately $10.0 million in a registered direct offering. The warrants have an exercise price of $1.00 per share and will expire five years from the date of issuance. The closing of the offering is expected to take place on or about September 15, 2016, subject to the satisfaction of customary closing conditions.
Rodman & Renshaw, a unit of H.C. Wainwright & Co., LLC, acted as the exclusive placement agent in connection with this offering.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)